Brind.

Medicare has approved coverage for the drug Leqembi, provided by Biogen and Eisai, under specific conditions.

1 report, 1 independent Updated Sat 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Medicare Biogen Eisai

Keep exploring

The entities involved

Medicare
US federal health insurance
- Congress enacted legislation on July 1st changing Medicare payment rules.02:43
- Hakeem Jeffries promised to ban congressional stock trading while lawmakers considered Medicare reforms.01:42
Biogen
American multinational biotechnology company
- Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.Wed 12:15
Eisai
Japanese pharmaceutical company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sat 00:00aol.com